IBB: Still a Correction within a Bigger Uptrend (Free)

I wrote about the Biotech ETF (IBB) on February 28th as it pulled back from a new high. The pullback was viewed as a correction within the bigger uptrend, but the correction extended further than expected. At the time, I drew a falling wedge on the chart and marked resistance with the red line at 163.

IBB: Still a Correction within a Bigger Uptrend (Free) Read More »